Richard Yost,, Ph.D., has received the Pittsburgh Analytical Chemistry Award. This prestigious award recognizes a scientist’s significant contributions to the field of analytical chemistry including the introduction of a significant technique, theory or instrument and providing exceptional training in analytical chemistry.

Duane Mitchell, M.D., Ph.D., is leading an effort to identify barriers to success for Blacks in the biomedical field and to develop strategies for them to thrive.

“Biomedical research is integral to translation of scientific findings to health care policy and clinical bedside practice,” Mitchell said. “Biomedical professionals who themselves identify as Black, and understand issues relevant to the Black community, are most qualified to produce culturally sensitive research.” READ MORE

Raymond Mailhot Vega, M.D., M.P.H., received a $247,000 grant from the Florida Department of Health’s Live Like Bella Pediatric Cancer Research Initiative for his research titled, “Measuring the effects of brain radiotherapy and tumor on scholastic outcome.”

Juan Hincapie-Castillo, Pharm.D., Ph.D., has been appointed as member of the Editorial Advisory Board, or EAB, of the Journal of the American Pharmacists Association, or JAPhA, for a three-year term. READ MORE

Vakaramoko “Karam” Diaby, Ph.D., M.Sc., led a team of researchers who placed third in the PhRMA Foundation’s Challenge Award contest aimed at addressing health disparities and underrepresented groups in value assessment. READ MORE

Daohong Zhou, M.D., participated in the National Institutes of Health Outstanding Investigator Award (R35) study section.

The BCL-XL PROTAC DT2216 developed by Daohong Zhou, M.D., Guangrong Zheng, Ph.D., and Weizhou Zhang, Ph.D., has been approved as an IND by the FDA and will be in phase I clinical studies in the first half of the year.

Christian Jobin, Ph.D., received a $1,361,412 NCI Multi-PI R01 CA200395 grant for his study titled, “Exploiting microbiota metabolism for colorectal cancer prevention.”

Nosha Farhadfar, M.D., gave two presentations: “Severity of Acute Graft-Versus-Host Disease and Associated Healthcare Resource Utilization, Cost and Outcomes” on Feb. 8, and “Gut Microbiota Dysbiosis Associated with Persistent Fatigue in Hematopoietic Cell Transplantation Survivors” on Feb. 9.

Dr. Farhadfar also presented a proposal to the Center for International Blood and Marrow Transplantation (CIBMTR) during a TCT meeting that was accepted — proposal #2010-180 “Racial, Ethnicity and Socioeconomic Disparity in Outcome of Patients with Chronic Graft versus Host Disease.”

Dejana Braithwaite, Ph.D., participated in the National Institutes of Health Health Services Quality and Effectiveness (HSQE) study section.

Michael Gutter, Ph.D., and Elizabeth Shenkman, Ph.D., received a USDA Telemedicine Infrastructure Grant that will establish telemedicine capacity in 13 rural county extension offices. The goal is to create access for rural oncology, cardio, and pediatric endocrinology patients who lack sufficient access to broadband for telemedicine at home.